COMPARATIVE STUDY
ENGLISH ABSTRACT
JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

[Atrial fibrillation, comorbidities and new anticoagulants].

UNLABELLED: The atrial fibrillation (AF) is one of the most important cause of arythmia and cerebrovascular disease in clinical practice. Comorbidity is defined as the association of active chronical diseases and a target disease.

METHOD: comparison between burden illness of the patients in interventional (n=4) and observational studies, form Medline database (n=4), was performed.

RESULTS: the level of comorbidity tend to be higher in patients from interventional than large observational studies.

DISCUSSION: in interventional studies, the level cerebro-vascular risk was calculated to compare interventional and control groups. So contrary to what was expected the patients of the general population who can receive anticoagulants have a lesser burden of illness. A recent paper studying new anticoagulants in general population finds this difference again, and would indicate that the risk related to the use of new anticoagulants would not be upper to that observed in the princeps pivotal studies.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app